Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:33 AM
Ignite Modification Date:
2025-12-25 @ 12:33 AM
NCT ID:
NCT05430867
Eligibility Criteria:
Inclusion Criteria:
* age of 50-80 years old , either sex;
* met the diagnostic criteria for suspected AD;
* moderate to severe AD patients(5 points ≤Mini-Mental State Examination total score≤14 points);
* total Hachinski ischemic scale (HIS) score ≤4 points;
* memory loss for at least 12 months, with a progressive deterioration;
* brain MRI scan suggesting a significant possibility of AD;
* no obvious physical signs during nervous system examination;
* stable and reliable caregivers;
* elementary school or higher education level;
* signed an informed consent form.
Exclusion Criteria:
* previous nervous system diseases ;
* mental illness;
* unstable or severe heart, lung, liver, kidney, or hematopoietic diseases;
* uncorrectable visual and auditory disorders;
* simultaneous use of cholinesterase inhibitors, memantine or GV-971.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
50 Years
Maximum Age:
80 Years
Study:
NCT05430867
Study Brief:
Protocol Section:
NCT05430867